NASDAQ:AVXL
Anavex Life Sciences Corp. Stock News
$3.80
-0.270 (-6.63%)
At Close: Apr 18, 2024
Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference
07:30am, Thursday, 11'th Apr 2024
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therape
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
07:30am, Monday, 25'th Mar 2024
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therape
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
07:30am, Monday, 26'th Feb 2024
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeu
Anavex Life Sciences Corp. (AVXL) Q1 2024 Earnings Call Transcript
12:46pm, Wednesday, 07'th Feb 2024
Anavex Life Sciences Corp. (AVXL) Q1 2024 Earnings Call Transcript
Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024
07:30am, Thursday, 01'st Feb 2024
Webcast and Conference Call To be Held Wednesday, February 7th, 2024, 8:30 am ET Webcast and Conference Call To be Held Wednesday, February 7th, 2024, 8:30 am ET
GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
01:16pm, Wednesday, 31'st Jan 2024
GSK's revenues benefit from strong growth across all segments, especially the Shingles and RSV vaccines. The company also issues fresh 2024 guidance for all its segments.
Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 530.68%: Here's is How to Trade
10:56am, Wednesday, 31'st Jan 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 530.7% in Anavex Life Sciences (AVXL). While the effectiveness of this highly sought-after metric is questionab
New Strong Buy Stocks for January 31st
07:05am, Wednesday, 31'st Jan 2024
ADMA, IKT, YPF, AVXL and EKSO have been added to the Zacks Rank #1 (Strong Buy) List on January 31, 2024.
New Strong Buy Stocks for January 26th
07:26am, Friday, 26'th Jan 2024
IKT, EGO, MDB, PD and AVXL have been added to the Zacks Rank #1 (Strong Buy) List on January 26, 2023.
Anavex Life Sciences (AVXL) Upgraded to Strong Buy: Here's Why
01:01pm, Wednesday, 24'th Jan 2024
Anavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for January 24th
06:56am, Wednesday, 24'th Jan 2024
ADMA, PBPB, YPF, CM and AVXL have been added to the Zacks Rank #1 (Strong Buy) List on January 24, 2023.
Anavex (AVXL): Strong Industry, Solid Earnings Estimate Revisions
09:46am, Tuesday, 09'th Jan 2024
Anavex (AVXL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
5 Small-Cap Stocks to Play the January Effect
11:17am, Monday, 08'th Jan 2024
Anavex Life Sciences (AVXL), Peakstone Realty Trust (PKST), AC Immune (ACIU), Getaround (GETR) and Akoya Biosciences (AKYA) could be solid picks to play the January Effect.
Anavex Life Sciences shares tank on Rett Syndrome trial results but analysts remain positive
01:49pm, Thursday, 04'th Jan 2024
Anavex Life Sciences (NASDAQ:AVXL) shares plunged this week on mixed results from its Rett Syndrome clinical study but analysts at Dawson James still see the stock as a worthwhile investment. The c
Anavex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
07:30am, Wednesday, 03'rd Jan 2024
NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeu
